Portside Wealth Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
2,147
+326
+18% +$69.9K 0.05% 321
2026
Q1
$403K Buy
1,821
+27
+2% +$6.61K 0.05% 302
2025
Q4
$455K Buy
1,794
+90
+5% +$22.6K 0.06% 279
2025
Q3
$422K Buy
1,704
+77
+5% +$18.4K 0.06% 298
2025
Q2
$391K Buy
1,627
+11
+0.7% +$2.56K 0.06% 290
2025
Q1
$366K Buy
1,616
+253
+19% +$55.6K 0.06% 282
2024
Q4
$280K Buy
1,363
+125
+10% +$27.4K 0.05% 337
2024
Q3
$300K Sell
1,238
-1,353
-52% -$316K 0.05% 305
2024
Q2
$569K Sell
2,591
-64
-2% -$13.9K 0.11% 187
2024
Q1
$597K Sell
2,655
-4
-0.2% -$902 0.11% 192
2023
Q4
$585K Buy
2,659
+15
+0.6% +$3.17K 0.11% 190
2023
Q3
$580K Buy
2,644
+16
+0.6% +$3.62K 0.11% 173
2023
Q2
$591K Buy
+2,628
New +$526K 0.11% 179

Other funds holding STE

Portside Wealth Group's STE Position: Q2 2026 in Review

Portside Wealth Group increased its Steris (STE) stake by 18% in Q2 2026, buying an estimated $69.9K and bringing the position to 2,147 shares worth $452K. The position accounts for 0.05% of the portfolio, ranked #321.

Portside Wealth Group first reported a position in STE in Q2 2023 and has held it in 13 quarters since. The position peaked at $597K in Q1 2024. 91 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Portside Wealth Group held 2,147 shares of Steris worth $452K as of Q2 2026.
  • Portside Wealth Group bought 326 Steris shares in Q2 2026, an estimated $69.9K.
  • Steris made up 0.05% of Portside Wealth Group's portfolio in Q2 2026, its #321 holding.
  • Portside Wealth Group first reported a position in Steris in Q2 2023 and has held it in 13 quarters since.
  • Portside Wealth Group's Steris position peaked at $597K in Q1 2024.
  • 91 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.